Atlas Trials

Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study

Clinical trial NCT06991894 · COMPLETED

Trial details

NCT number
NCT06991894
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Anemia, Aplastic
Start date
2021-07-14
Primary completion
2024-05-17
Enrollment
2517

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.